Drugs / MMF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00920972 Background | Dec 2001 → Dec 2026 expected | inherited hemoglobinopathy, metabolic disease | Washington University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMF | “Begin Tacrolimus or cyclosporine Begin MMF” NCT00920972 ↗ |